|
EXO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.69544411632705E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8294999999946E-05 |
| Normal-vs-Stage2 |
4.500500E-02 |
| Normal-vs-Stage3 |
1.74412999999207E-05 |
| Normal-vs-Stage4 |
2.614300E-02 |
| Stage1-vs-Stage2 |
5.086800E-01 |
| Stage1-vs-Stage3 |
3.611300E-04 |
| Stage1-vs-Stage4 |
6.779700E-02 |
| Stage2-vs-Stage3 |
4.897900E-03 |
| Stage2-vs-Stage4 |
1.097020E-01 |
| Stage3-vs-Stage4 |
9.715400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03599995249226E-09 |
| Normal-vs-AfricanAmerican |
1.842510E-04 |
| Normal-vs-Asian |
8.155800E-02 |
| Caucasian-vs-AfricanAmerican |
2.649400E-01 |
| Caucasian-vs-Asian |
5.573600E-01 |
| AfricanAmerican-vs-Asian |
1.911610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8839000359705E-09 |
| Normal-vs-Female |
1.57929999999862E-06 |
| Male-vs-Female |
1.406380E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.446500E-04 |
| Normal-vs-Extreme_Weight |
1.15820000001765E-06 |
| Normal-vs-Obese |
7.69740000000629E-05 |
| Normal-vs-Extreme_Obese |
1.997450E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.937700E-02 |
| Normal_Weight-vs-Obese |
8.685400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.676400E-03 |
| Extreme_Weight-vs-Obese |
2.325700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.298000E-02 |
| Obese-vs-Extreme_Obese |
1.738190E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.661200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.61619997782492E-09 |
| Normal-vs-Age(61-80Yrs) |
4.14349999999786E-05 |
| Normal-vs-Age(81-100Yrs) |
3.219900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.028000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.352300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.332000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.367400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.192300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.645400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.85130000000178E-05 |
| Normal-VS-Type2 PRCC |
3.23239999999725E-06 |
| Normal-VS-KIRP CIMP |
1.419610E-03 |
| Normal-VS-Unclassified PRCC |
1.099730E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.229830E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.744600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.356570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.379100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.961600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.278100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.446950E-04 |
| Normal-vs-N1 |
1.017920E-04 |
| Normal-vs-N2 |
8.521800E-02 |
| N0-vs-N1 |
1.201580E-03 |
| N0-vs-N2 |
9.854200E-02 |
| N1-vs-N2 |
3.618600E-01 |
|
|
